F. Fazio, “MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023047, Aug. 2023.